{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:42:30Z","timestamp":1753890150673,"version":"3.41.2"},"reference-count":20,"publisher":"Siapec Servizi Srl","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathologica"],"DOI":"10.32074\/1591-951x-291","type":"journal-article","created":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T10:48:15Z","timestamp":1651142895000},"page":"138-145","source":"Crossref","is-referenced-by-count":1,"title":["Descriptive analysis of incidental and operable gallbladder carcinoma cases: a UK centre experience"],"prefix":"10.32074","volume":"114","author":[{"given":"Sanwandana","family":"Karunaratne","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amila","family":"Gamage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Izhar N.","family":"Bagwan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"21774","published-online":{"date-parts":[[2022,4]]},"reference":[{"key":"10.32074\/1591-951X-291_ref1","doi-asserted-by":"crossref","unstructured":"Krishnatreya M, Saikia A, Kataki AC et al. Variations in spatial distribution of gall bladder cancer: a call for collaborative action. Ann Med Health Sci Res 2014;4 (Suppl 3):S329-331. https:\/\/doi.org\/10.4103\/2141-9248.141984.","DOI":"10.4103\/2141-9248.141984"},{"key":"10.32074\/1591-951X-291_ref2","unstructured":"Haq N, Khan BA, Imran M et al. Frequency of gall bladder carcinoma in patients with acute and chronic cholecystitis. J Ayub Med Coll Abbottabad 2014;26:191-193."},{"key":"10.32074\/1591-951X-291_ref3","doi-asserted-by":"crossref","unstructured":"Sharma JD, Kalita I, Das T et al. A retrospective study of post-operative gall bladder pathology with special reference to incidental carcinoma of the gall bladder. Int J Res Med Sci 2014;2:1050-1053.","DOI":"10.5455\/2320-6012.ijrms20140871"},{"key":"10.32074\/1591-951X-291_ref4","unstructured":"Adsay NV, Klimstra DS. Benign and malignant tumours of the gallbladder and extrahepatic biliary tract. In: Odze RD, Goldblum JR, eds. Surgical pathology of the GI tract, liver, biliary tract and pancreas (3rd edition). Philadelphia: Saunders Elsevier 2015, pp. 1021-1054."},{"key":"10.32074\/1591-951X-291_ref5","unstructured":"Wyatt J, Huebscher S, Goldin R. Dataset for histopathology reporting of liver resection specimens (including gall bladder) and liver biopsies for primary and metastatic carcinoma (2nd edition). London: The Royal College of Pathologists 2012."},{"key":"10.32074\/1591-951X-291_ref6","unstructured":"Weinstein D, Herbert M, Bendet N et al. Incidental finding of gall bladder carcinoma. Isr Med Assoc J 2002;4:334-336."},{"key":"10.32074\/1591-951X-291_ref7","doi-asserted-by":"crossref","unstructured":"Duffy A, Capanu M, Abou-Alfa GK et al. Gallbladder cancer (GBC): 10-year experience at Memorial Sloan-Kettering Cancer Centre (MSKCC). J Surg Oncol 2008;98:485-489. https:\/\/doi.org\/10.1002\/jso.21141","DOI":"10.1002\/jso.21141"},{"key":"10.32074\/1591-951X-291_ref8","doi-asserted-by":"crossref","unstructured":"Uribe-Uribe NO, Jimenez-Garduno AM, Henson DE et al. Paraneoplastic sensory neuropathy associated with small cell carcinoma of the gallbladder. Ann Diagn Pathol 2009;13:124-126. https:\/\/doi.org\/10.1016\/j.anndiagpath.2007.08.003","DOI":"10.1016\/j.anndiagpath.2007.08.003"},{"key":"10.32074\/1591-951X-291_ref9","doi-asserted-by":"crossref","unstructured":"Pandey M, Shukla VK. Lifestyle, parity, menstrual and reproductive factors and risk of gallbladder cancer. Eur J Cancer Prev 2003;12:269-272. https:\/\/doi.org\/10.1097\/00008469-200308000-00005","DOI":"10.1097\/00008469-200308000-00005"},{"key":"10.32074\/1591-951X-291_ref10","doi-asserted-by":"crossref","unstructured":"Everson GT, McKinley C, Kern F Jr. Mechanisms of gallstone formation in women. Effects of exogenous oestrogen (Premarin) and dietary cholesterol on hepatic lipid metabolism. J Clin Invest 1991;87:237-246. https:\/\/doi.org\/10.1172\/JCI114977","DOI":"10.1172\/JCI114977"},{"key":"10.32074\/1591-951X-291_ref11","doi-asserted-by":"crossref","unstructured":"Arroyo GF, Gentile A, Parada LA. Gallbladder cancer: South American experience. Chin Clin Oncol 2016;5:67. https:\/\/doi.org\/10.21037\/cco.2016.10.01","DOI":"10.21037\/cco.2016.10.01"},{"key":"10.32074\/1591-951X-291_ref12","doi-asserted-by":"crossref","unstructured":"Do SI, Lee HW, Sohn JH et al. Clinicopathologic characteristics of young patients with gallbladder cancer. Pathol Res Pract 2017;213:189-193. https:\/\/doi.org\/10.1016\/j.prp.2016.12.021","DOI":"10.1016\/j.prp.2016.12.021"},{"key":"10.32074\/1591-951X-291_ref13","unstructured":"Tomimaru Y, Noguchi K, Nagase H et al. Clinicopathological study of incidental gallbladder cancer diagnosed after laparoscopic cholecystectomy. Gan To Kagaku Ryoho 2016;43:1605-1607."},{"key":"10.32074\/1591-951X-291_ref14","doi-asserted-by":"crossref","unstructured":"Ethun CG, Le N, Lopez-Aguiar AG et al. Pathologic and prognostic implications of incidental versus non incidental gallbladder cancer: a 10 institution study from the United States extrahepatic biliary malignancy consortium. Am Surg 2017;83:679-686.","DOI":"10.1177\/000313481708300721"},{"key":"10.32074\/1591-951X-291_ref15","doi-asserted-by":"crossref","unstructured":"Goetze TO. Gallbladder carcinoma: prognostic factors and therapeutic options. World J Gastroenterol 2015;21:12211-12217. https:\/\/doi.org\/10.3748\/wjg.v21.i43.12211","DOI":"10.3748\/wjg.v21.i43.12211"},{"key":"10.32074\/1591-951X-291_ref16","doi-asserted-by":"crossref","unstructured":"Miller G, Jarnagin WR. Gallbladder carcinoma. Eur J Surg Oncol 2008;34:306-312. https:\/\/doi.org\/10.1016\/j.ejso.2007.07.206","DOI":"10.1016\/j.ejso.2007.07.206"},{"key":"10.32074\/1591-951X-291_ref17","doi-asserted-by":"crossref","unstructured":"Fuks D, Regimbeau JM, Le Treut YP et al. Incidental Gallbladder cancer by the AFC-GBC-2009 Study Group. World J Surg 2011;35:1887-1897. https:\/\/doi.org\/10.1007\/s00268-011-1134-3","DOI":"10.1007\/s00268-011-1134-3"},{"key":"10.32074\/1591-951X-291_ref18","doi-asserted-by":"crossref","unstructured":"Birnbaum DJ, Vigano L, Ferrero A, et al. Locally advanced gallbladder cancer: which patients benefit from resection? Eur J Surg Oncol 2014;40:1008-1015. https:\/\/doi.org\/10.1016\/j.ejso.2013.10.014","DOI":"10.1016\/j.ejso.2013.10.014"},{"key":"10.32074\/1591-951X-291_ref19","doi-asserted-by":"crossref","unstructured":"Chen C, Geng Z, Shen H et al. Long-term outcomes and prognostic factors in advanced Gallbladder cancer: focus on the advanced T Stage. PLoS One 2016;11:e0166361. https:\/\/doi.org\/10.1371\/journal.pone.0166361","DOI":"10.1371\/journal.pone.0166361"},{"key":"10.32074\/1591-951X-291_ref20","doi-asserted-by":"crossref","unstructured":"Margonis GA, Gani F, Buettner S, et al. Rates and patterns of recurrence after curative intent resection for gallbladder cancer: a multi-institution analysis from the US Extra-hepatic Biliary Malignancy Consortium. HPB (Oxford) 2016;18:872-878. https:\/\/doi.org\/10.1016\/j.hpb.2016.05.016","DOI":"10.1016\/j.hpb.2016.05.016"}],"container-title":["Pathologica"],"original-title":[],"link":[{"URL":"https:\/\/www.pathologica.it\/article\/view\/291","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T13:25:59Z","timestamp":1730813159000},"score":1,"resource":{"primary":{"URL":"https:\/\/old.pathologica.it\/article\/view\/291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":20,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,4]]}},"URL":"https:\/\/doi.org\/10.32074\/1591-951x-291","relation":{},"ISSN":["1591-951X"],"issn-type":[{"type":"electronic","value":"1591-951X"}],"subject":[],"published":{"date-parts":[[2022,4]]},"article-number":"3"}}